Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A commentary by SPCR researcher Richard McManus (University of Oxford) and Jonathan Mant (University of Cambridge) was published in a special edition of The Lancet medical journal today.

They corroborate with researchers from Imperial College London whose research indicates that if the current advances in the diagnosis, treatment and management of blood pressure continue unabated until 2022, then 80% of patients will be on effective medication. (The Telegraph, and Mail Online, 30 May, 2014).

Commentary in The Lancet: The drugs do work: blood pressure improvement in England